Gene Symbol | BRI3BP |
---|---|
Entrez Gene | 140707 |
Alt Symbol | BNAS1, HCCR-1, HCCR-2, HCCRBP-1, KG19 |
Species | Human |
Gene Type | protein-coding |
Description | BRI3 binding protein |
Other Description | BRI3-binding protein|I3-binding protein|cervical cancer 1 proto-oncogene-binding protein KG19|cervical cancer oncogene binding protein |
Swissprots | Q8WY23 Q8WY22 |
Accessions | EAW98470 EAW98471 Q8WY22 AF283671 AAL33003 AF284094 AAL54382 AF441865 AAN76689 AK055703 BC034525 AAH34525 CA488612 XM_011537940 XP_011536242 NM_080626 NP_542193 |
Function | Involved in tumorigenesis and may function by stabilizing p53/TP53. {ECO:0000269|PubMed:17943721}. |
Subcellular Location | Mitochondrion outer membrane {ECO:0000305|PubMed:17943721}; Multi-pass membrane protein {ECO:0000305|PubMed:17943721}. |
Tissue Specificity | Most abundantly expressed in brain, liver and kidney. Overexpressed in leukemia and lymphoma cell lines, as well as in various carcinomas. {ECO:0000269|PubMed:11860200, ECO:0000269|PubMed:17943721}. |
Human BRI3BP full length protein - ab165475 from Abcam
|
||||||||||
BRI3BP Antibody Blocking Peptide - LS-E5419 from LifeSpan Bioscience
|
||||||||||
BRI3BP Antibody Blocking Peptide - LS-E18157 from LifeSpan Bioscience
|
||||||||||
Recombinant Human BRI3BP Protein - H00140707-P01 from Novus Biologicals
|
||||||||||
BRI3BP-Antibody-Center-Blocking-Peptide - BP17929c from Abgent, a WuXi AppTec company
|
||||||||||
BRI3BP Blocking Peptide - 33R-3270 from Fitzgerald
|
||||||||||
BRI3BP - H00140707-P01-10 from Acris Antibodies
|
||||||||||
BRI3BP - H00140707-P01-25 from Acris Antibodies
|
||||||||||
BRI3BP fusion protein - ag14829 from Proteintech Group
|
||||||||||
BRI3BP Recombinant Protein Antigen - NBP1-88564PEP from Novus Biologicals
|
||||||||||
BRI3BP Peptide, Human - M34GP01536H from Creative Peptides
|
||||||||||
BRI3-binding protein (BRI3BP), Recombinant Protein - MBS7010452 from MyBioSource
|